Investing.com -- Hyperfine, Inc. (NASDAQ:HYPR) stock climbed 8.4% in Monday’s premarket trading after the company announced FDA clearance for a new multi-direction diffusion-weighted imaging (DWI) ...

RAD 101 achieved concordance¹ with MRI imaging (the primary endpoint) with significant and selective tumor uptake in ...

The health system's chief physician executive tells the story of 10,000 potentially critical findings available to ...

RAD 101 is Radiopharm’s novel small-molecule imaging agent targeting fatty acid synthase (FASN) and radiolabelled with Fluorine-18 for the diagnosis of suspected recurrent brain metastases from solid ...

Booking Health, a leading platform for international medical travel, announced today the release of its 2026 rankings of ...

A little-known South Melbourne firm is quietly powering a revolution for Apple — one that stretches from Hollywood’s hi-tech ...